Revista médica de Chile
-
Revista médica de Chile · Oct 2007
Multicenter Study Clinical Trial[Biphasic insulin aspart for the management of diabetic patients with unsatisfactory metabolic control].
Biophasic insulin aspart (InAsBi) is a mixture of 30% of rapid acting soluble aspart insulin and 70% aspart insulin retarded with protamine. The soluble portion reduces postprandial serum glucose rises and the retarded portion reduces basal glucose levels. ⋯ In this group of diabetic patients with a bad metabolic control, the use of InAsBi was associated with a significant reduction of glycosilated hemoglobin levels.
-
Revista médica de Chile · Oct 2007
[Intraoperative diastolic dysfunction as a risk factor for hemodynamic instability].
Diastolic function can be evaluated intraoperatively using transesoptiageal echocardiography. ⋯ In this group of patients with cardiovascular disease, intraoperative diastolic dysfunction is a risk factor for hemodynamic instability.